CMS’s comment period for the FY 2027 Inpatient Prospective Payment System proposed rule closed June 9, 2026. The rule proposes to adopt the Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate Following Sepsis Hospitalization measure into the Hospital Readmissions Reduction Program (HRRP), with an “early look” in FY 2028 and payment consequences beginning the FY 2029 program year. HRRP already cuts up to 3% of a hospital’s base Medicare operating payments for excess readmissions on six condition cohorts; sepsis would become the seventh, and the highest-volume one.
This is the second sepsis pressure point CMS has built in three years. Severe sepsis and septic shock early-management bundle compliance (SEP-1) entered the Hospital Value-Based Purchasing program’s Safety domain in FY 2026, so a hospital’s sepsis process is already inside the payment formula. The proposed HRRP measure adds the outcome to the process: not just whether the bundle was delivered, but whether the patient came back within 30 days. For self-insured hospitals and hospital captives, that combination is what makes this a reserve item rather than a compliance footnote.
Why sepsis is the file that changes character
Sepsis is the largest single cost center in the hospital. AHRQ’s HCUP data ranked septicemia the most expensive inpatient condition treated in the United States in 2022 at $60.0 billion, 10.9% of aggregate hospital costs, and Medicare paid the majority of it. The CDC estimates at least 1.7 million adults develop sepsis each year and at least 350,000 die. It is also the leading readmission diagnosis: an analysis of the Nationwide Readmissions Database found sepsis drives 12.2% of all readmissions, ahead of heart failure at 6.7% and pneumonia at 5%, at roughly $3.5 billion a year.
That profile is exactly the kind that flips from a routine incident report to a serious liability file once the chart is read closely. From watching hospital claim reviews, sepsis cases turn on the same allegations that drive professional liability severity: failure to recognize deterioration, delayed escalation, weak discharge instructions, and poor follow-up after a high-risk admission. A 30-day readmission is, in plaintiff terms, a documented adverse outcome with a timestamp.
The reserve mechanism: a sharper severity signal on a worsening line
The lever is case adequacy on hospital professional liability, and the backdrop is a line that is already deteriorating. Milliman’s 2025 medical professional liability update, built on roughly 40,000 closed claims from 2014 through 2023 and more than $26 billion in incurred losses, puts the severity trend at 5.0% on an unlimited basis and 4.5% limited to $5 million per claim, and states plainly that the hospital professional liability market has seen an uptick in severity. The driver is the tail: a rising frequency of claims closing at $5 million or more, pushed by social inflation and third-party litigation funding. The AMA’s 2025 premium analysis shows the market response, with med-mal premiums rising for a seventh straight year and 11 states posting double-digit increases even as claim frequency declines.
A new public measure does not raise that trend; it raises the speed at which a hospital’s own bad files become legible. When CMS publishes a risk-standardized sepsis readmission rate, the events behind it become discoverable, benchmarkable, and citable. Plaintiff counsel gets a federal yardstick; quality staff get a flag months before claims staff do. The reserve failure is the lag: if open files carrying failure-to-rescue or discharge-planning allegations sit at routine-complication values until a demand letter, expert review, or deposition forces the issue, the severity arrives as case reserve strengthening late in the reported triangle rather than as an adequate first reserve.
There is a frequency wrinkle worth naming. The clinical evidence that SEP-1 compliance reduces mortality is genuinely mixed; a 2025 systematic review found no high-grade evidence overall, even though a large Medicare study (Townsend et al., 245,740 patients) reported a 5.7% adjusted absolute reduction in mortality for bundle-compliant care. For reserving, the contested evidence cuts toward caution, not comfort: a hospital can be fully bundle-compliant on the SEP-1 process and still post a high readmission rate and still face a preventability allegation. Compliance is not a liability shield.
What this means for hospital self-insureds and captives
Read it as a timing and triage issue, not a new loss layer. The directional call is that sepsis-related HPL reserves should be biased upward at the case level, and sooner, for hospitals with meaningful Medicare inpatient volume; the severity trend is already 5% and the public data will compress the recognition window further. Three concrete moves for the next reserve study or interim claims meeting:
- Make sepsis a coded segment. Confirm the claim extract flags sepsis, 30-day readmission, service line, discharge disposition, and allegation type, so claims, quality, and actuarial teams are reading the same cohort rather than the same pattern in separate rooms.
- Re-underwrite open sepsis files against the leading indicators of adverse development, especially days to first reserve and attorney involvement. The cohort to scrutinize is files held at routine values where the record shows missed deterioration or thin discharge documentation.
- Stress the severity selection. A 5% unlimited trend with a thickening $5 million tail means recent-year sepsis files should not be reserved off pre-2020 averages; align the captive’s HPL severity assumption with the published trend, not a blended legacy number.
This is the same dynamic flagged in the companion CMS mortality-measure analysis: the FY 2027 rule is quietly converting Medicare quality data into case-adequacy signals for self-insured hospitals. It compounds with two other 2026 shifts already widening the standard-of-care surface, the Joint Commission NPG 12 staffing standard and Virginia’s SB 536 claims-disclosure law. None of these creates liability on its own. Together they mean a sepsis pattern your quality team can already see should not be the last thing your reserve analysis learns about.
Sources
- CMS FY 2027 IPPS Proposed Rule Home Page
- CMS FY 2027 IPPS proposed rule fact sheet (CMS-1849-P)
- Hall Render: CMS Publishes FY 2027 IPPS Proposed Rule (sepsis readmission measure, FY 2029)
- AHRQ HCUP Statistical Brief: Most Expensive Inpatient Conditions by Payer, 2022 (septicemia $60.0B)
- CDC and AMA: sepsis affects ~1.7 million adults and kills at least 350,000 annually
- UCLA Health / Becker’s: sepsis is the leading readmission diagnosis (Nationwide Readmissions Database)
- Milliman: 2025 Medical Professional Liability Update (severity ~5%, HPL uptick)
- Systematic review of SEP-1 compliance and sepsis mortality (PMC, 2025)
- Medisolv: SEP-1 added to Hospital Value-Based Purchasing Safety domain in FY 2026